Background
==========

Obstructive sleep apnea syndrome (OSAS) is a nocturnal disorder that occurs especially in men with metabolic syndrome (MS). characterized by increased cardiovascular risk \[[@b1-medscimonit-19-111].[@b2-medscimonit-19-111]\]. Recurrent pause of airflow during sleep is the characteristic feature of OSAS. ultimately leading to increased respiratory effort. oxyhemoglobin desaturation. and excessive daytime sleepiness \[[@b3-medscimonit-19-111]\]. Patients with OSAS are often overweight and they frequently have a higher incidence of arterial hypertension. coronary heart disease. and cerebrovascular disease \[[@b4-medscimonit-19-111]\]. OSAS is a risk factor for systemic hypertension and there is a strict relation between OSAS and MS \[[@b5-medscimonit-19-111].[@b6-medscimonit-19-111]\]. Several studies have found increased insulin resistance and impaired glucose tolerance in OSAS patients. independent of body weight \[[@b6-medscimonit-19-111]--[@b11-medscimonit-19-111]\]. Intermittent hypoxia and oxidative stress may play important roles in the pathogenesis of OSAS \[[@b12-medscimonit-19-111].[@b13-medscimonit-19-111]\].

On physical examination very few features have been helpful in defining the risk for OSAS and the response to therapy. Several reports have emphasized that a thick neck or a large neck is an important variable \[[@b14-medscimonit-19-111]\]. However. neck circumference (NC) and body mass index (BMI) are highly correlated. whereas gain in waist circumference (WC) over adult life has a stronger association than neck size with sleep-disordered breathing severity \[[@b15-medscimonit-19-111]--[@b17-medscimonit-19-111]\]. The National Cholesterol Educational Program (NCEP). Adult Treatment Panel (ATP)-III proposed a clinically practical approach that establishes the diagnosis of MS when an individual has 3 of these 5 characteristics: increased WC. high blood pressure. increased fasting glucose. increased triglycerides. and decreased high=density lipoprotein (HDL) cholesterol \[[@b18-medscimonit-19-111]\].

The aim of the present study was to evaluate the MS in patients with severe and non-severe OSAS (AHI \<30 non-severe. ≥30 severe OSAS) according to NCEP-ATP-III criteria \[[@b18-medscimonit-19-111]\].

Material and Methods
====================

Sample population
-----------------

This study enrolled of 44 patients (25 males. 19 females) at the Istanbul Yedikule Chest Diseases Training and Research Hospital Sleep Disorders Unit. Clinical and biochemical observations were performed with all patients. The study protocol was approved by the local ethics committee and informed consent was obtained from every patient. Subjects with heart. neurological. autoimmune. chronic renal and liver diseases were excluded.

Measurements
------------

Blood pressure was measured twice with a mercury sphygmomanometer from the right arm of patients in a sitting position after 5 minutes of rest. and average value was calculated. Height (m). weight (kg). NC. and WC (cm) were measured. Weight was measured with light clothing and without shoes. BMI was calculated as weight (kg) divided by height (m^2^). NC was measured at the middle of the neck between the mid-cervical spine and superior line of the cricothyroid membrane. in a standing position. WC was measured between the lowest rib and the crista iliaca superior. MS was diagnosed according to the National Cholesterol Education Program. Adult Treatment Panel (ATP)-III criteria by presence of at least 3 of 5 criteria: (1) WC ≥94 cm for male. ≥80 cm for female; (2) arterial blood pressure ≥130/85 mmHg or presence of drug treatment for hypertension; (3) fasting blood glucose ≥100 mg/dl or drug treatment for hyperglycemia; (4) HDL Cholesterol \<40 mg/dl in man. \<50 mg/dl in women; (5) triglycerides ≥150 mg/dl or drug treatment for elevated triglyceride levels. Fasting blood glucose. urea. creatinine. hemoglobin A~1~c. insulin. high sensitive C-reactive protein (hsCRP). cholesterol levels (HDL. LDL. triglyceride. total cholesterol) by using Abbot Architech Analisator system (IL. USA). The homeostasis model assessment for insulin resistance (HOMA-IR) was calculated with the following formula: fasting blood glucose (mmol/l) × \[insulin (mU/l)/22.5\] \[[@b19-medscimonit-19-111]\].

Polysomnography
---------------

An overnight polysomnography (Embla Flaga Inc.. Iceland) was performed for all patients at the sleep laboratory. and electroencephalography. electrooculography. oral-nasal airflow. pulse oximetry. chest and abdominal movement. body position. and snoring noise were recorded. Apnea is a pause of airflow more than 10 seconds. and hypopnea is a decrease of airflow more than 10 seconds and oxygen desaturation of 4% or greater. The apnea/hypopnea index (AHI) was measured to evaluate the severity of OSAS. AHI ≥30 was described as severe OSAS. and AHI \<30 was described as non-severe (mild and moderate) OSAS. Patients were divided into 2 comparable groups as severe and non-severe OSAS.

Statistical analysis
--------------------

Statistical analysis was carried out by using SPSS for Windows version 16.0. Results are expressed as mean ± standard deviation. Kolmogorov Smirnov Z test was performed to determine the distribution of variables for each patients group. Regular variances were assessed with t test and irregulars with Mann-Whitney U test. The Pearson and the Spearman tests were performed to analyze the correlation between variables. Logistic regression modeling was performed to identify relationship between severe OSAS; independent variables were metabolic parameters and NC. Chi square test was used to evaluate categorical variables. A P value \<0.05 was statistically significant.

Results
=======

The mean age. AHI. BMI. and WC of OSAS patients did not differ among women and men. There was a statistical significance between men and women patients in mean waist/hip ratio and NC (p=0.006 and p\<0.001). Twenty-eight patients (63.6%) were hypertensive. and 7 patients (15.9%) were diabetic and under drug treatment. Mean total and LDL cholesterol. insulin. and hs CRP levels of OSAS patients were not different between women and men. Mean triglyceride level of male OSAS patients was significantly higher and HDL cholesterol was significantly lower than in female patients (p=0.007 and p=0.005). There were no differences in mean HOMA-IR and percentage of MS between sexes. The mean hemoglobin level of men was higher than in women (p\<0.001).

The clinical and laboratory findings of OSAS patients are given in [Table 1](#t1-medscimonit-19-111){ref-type="table"}. Twenty-five (56.8%) were severe and the remaining (19/44) were non-severe OSAS patients according to AHI criteria. Mean BMI and NC were higher in severe OSAS patients as compared to non-severe patients (p=0.021. p\<0.001). NC was correlated with BMI and waist circumference ([Figures 1](#f1-medscimonit-19-111){ref-type="fig"} and [2](#f2-medscimonit-19-111){ref-type="fig"}). A logistic regression model was performed to identify the relationship between severe OSAS and independent variables as metabolic parameters and NC ([Table 2](#t2-medscimonit-19-111){ref-type="table"}). As an important result. NC was an independent risk factor for severe OSAS (odds ratio \[OR\]: 1.55. 95% confidence intervals \[CI\]: 1.09--2.21. p=0.01). MS parameters were not statistically different among OSAS patients. Mean age. WC. waist/hip ratio. systolic and diastolic blood pressure. triglycerides. cholesterol levels. hemoglobin A1c. and hs CRP values were not statistically significant in OSAS patients. We found that 68% of severe and 55.6% of non-severe OSAS patients were hypertensive. Twenty-four percent of severe and 5.6% of non-severe OSAS patients were diabetic. There were a positive correlation between AHI and BMI (r=0.545, p\<0.01, [Figure 3](#f3-medscimonit-19-111){ref-type="fig"}) and a negative correlation between AHI and HDL cholesterol (r=--0.333, p=0.02, [Figure 4](#f4-medscimonit-19-111){ref-type="fig"}).

Mean HOMA-IR was not statistically significant between severe and non-severe OSAS patients. Sixty-four percent of severe and 61.1% of non-severe patients were MS according to ATP III criteria. but this difference was not statistically significant at α=0.05. The comparisons of OSAS patients according to AHI are given in [Table 3](#t3-medscimonit-19-111){ref-type="table"}. Comparison of OSAS patients for the presence of MS are indicated in [Table 4](#t4-medscimonit-19-111){ref-type="table"}. Mean BMI (p=0.042). WC (p=0.026). systolic blood pressure (p=0.023). hypertension (p=0.001). fasting blood glucose (p=0.001). and HbA~1~c levels were significantly higher in the patients with MS. There were no statistically significant differences at α=0.05 (p=0.84) between patients with and without MS. mean age. diastolic blood pressure. triglycerides. cholesterol. and hs CRP values.

Discussion
==========

Some recent studies analyzed the associations of OSAS patients with obesity and MS components. There is a relationship between MS and OSAS \[[@b20-medscimonit-19-111]\]. Prevalence of OSAS increases with age and it is most prominent in middle-aged people \[[@b21-medscimonit-19-111]\]. Tufik et al. identified AHI ≥15 and BMI as independent and strong associated factors for the presence of OSAS among overweight and obese subjects of both sexes \[[@b22-medscimonit-19-111]\]. This study was performed to assess NC. BMI and MS in severe and non-severe (mild-moderate) OSAS patients according to AHI (AHI \<30 non-severe. ≥30 severe OSAS). The study group consisted of 25 severe and 19 non-severe OSAS patients. In our study. mean BMI and WC were higher in patients with severe OSAS than in non-severe patients. Mean BMI was 34.55±7.39 and WC was 110.20±15.58 cm in patients with OSAS. There was a statistically significant different between severe and non-severe OSAS patients for BMI (p=0.02).

Papadavid et al. suggested that presence of MS was not a significant risk factor for OSAS in patients with psoriasis \[[@b23-medscimonit-19-111]\]. There was statistically significant evidence that only obesity and hypertension were associated with increased risk of OSAS. adjusting for psoriasis characteristics. metabolic parameters. age. and sex \[[@b24-medscimonit-19-111]\]. In our study. MS was identified in 64% of severe and 61% of non-severe OSAS patients. The prevalence of MS was not statistically different between the severe and non-severe OSAS patients. MS can develop as a result of sleep disorders \[[@b25-medscimonit-19-111]\]. Prevalence of MS was 5 times higher in OSAS patients than in normal individuals \[[@b26-medscimonit-19-111]\]. In our study. MS parameters were evaluated and 23 patients with OSAS had MS. Mean WC. BMI. systolic blood pressure. and fasting blood glucose values were significantly higher in OSAS patients with MS. In addition. 81.5% of all patients were hypertensive (p=0.001). According to a logistic regression model with independent variables. MS was not an independent risk factor for severe OSAS (OR: 0.31. 95% CI: 0.07--2.21. p=0.30).

Neck circumference (NC) is a newly identified clinical feature that may be associated with OSAS. NC is greater among man \[[@b27-medscimonit-19-111]\]. Higher NC and BMI in OSAS patients may be correlated with aerobic capacity. physical inactivity. and excess body fluid \[[@b28-medscimonit-19-111]\]. NC is a more effective factor in determining OSAS \[[@b29-medscimonit-19-111]\]. Onat et al. found that NC was a marker of central obesity. BMI. OSAS. blood pressure. and HOMA-assessed insulin resistance. In our study. we discovered that the NC in male patients was greater than in females (p\<0.001). Also. in the severe OSAS patients group. mean NC value was significantly greater than in the non-severe OSAS group (p\<0.001). There was a positive correlation between AHI and BMI (r=0.545. p\<0.01). Higher NC value was determined to be associated with severity of OSAS. is an independent risk for severe OSAS (p=0.01). and is an independent risk factor for severe OSAS (OR: 1.55. 95% CI: 1.09--2.21. p=0.01).

Among patients with OSAS. from 1/2 to 2/3 had hypertension; these patients should be identified and treated. In a study by Lavie et al. hypertension was found in 45.3% of 2677 OSAS patients \[[@b30-medscimonit-19-111]\]. and Nieto et al. found hypertension in 62.6% of 6132 patients with OSAS \[[@b31-medscimonit-19-111]\]. In this study. 63.3% of all OSAS patients and 68% of severe OSAS patients were hypertensive. Hypertension is an important cardiovascular condition and an independent risk factor for OSAS \[[@b32-medscimonit-19-111].[@b33-medscimonit-19-111]\]. Severity of OSAS may have an impact on displacement of HDL cholesterol. In The Sleep Heart Health Study. a relationship was determined between lower HDL cholesterol levels and severity of OSAS \[[@b34-medscimonit-19-111]\]. Coughlin et al. demonstrated that HDL cholesterol was lower in OSAS patients compared to a control group \[[@b35-medscimonit-19-111]\]. Triglycerides. HDL. LDL. and total cholesterol levels were not significantly different between groups in our study. but there was a negative correlation between AHI and mean HDL cholesterol level (r=--0.333. p=0.029).

The cross sectional design of this study to some extent limits the interpretation of obtained associations. Measurement of NC is a novel parameter for use in OSAS patients. In this respect. assessment of NC might be better in a large sample population to generate significant relations. The other limitation is the lack of a control group without OSAS.

Conclusions
===========

In conclusion. NC and BMI measurements were higher in severe OSAS patients compared to non-severe patients. Increased NC may be a greater risk factor for severe OSAS than are MS parameters.

**Source of support:** Departmental sources
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###### 

Mean clinical and laboratory findings of OSAS patients.

                              Women (n=19)   Men (n=25)      Total (n=44)   p value
  --------------------------- -------------- --------------- -------------- -------------
  Age (years)                 48.84±6.04     51.44±11.22     50.32±9.34     0.331
  AHI                         27.99±15.38    39.09±21.20     34.19±19.46    0.074
  BMI                         33.16±6.12     32.11±7.09      32.56±6.64     0.607
  Waist circumference(cm)     104.47±15.73   108.56±13.60    106.80±14.53   0.361
  Waist/hip ratio             0.94±0.08      1.00±0.05       0.97±0.07      **0.006**
  Neck circumference          35.68±2.65     41.36±4.02      38.91±4.48     **\<0.001**
  Hypertension (%)            63.2           64              63.6           0.954
  Diabetes mellitus (%)       15.8           16              15.9           0.985
  Triglycerides (mg/dl)       116.58±36.92   168.96±81.47    146.34±70.45   **0.007**
  Total cholesterol (mg/dl)   201.95±28.19   213.17±36.74l   208.32±33.43   0.276
  LDL cholesterol (mg/dl)     133.00±24.56   140.84±30.99    137.45±28.35   0.370
  HDL cholesterol (mg/dl)     46.58±10.00    38.29±8.64      41.87±10.04    **0.005**
  Hb A1c (%)                  5.56±0.38      6.00±0.68       5.81±0.61      **0.009**
  Insulin (IU/l)              7.85±3.64      13.60±12.61     11.20±10.21    0.335
  hs CRP (mg/l)               0.78±0.93      0.65±0.90       0.70±0.90      0.545
  Hemoglobin (gr/dl)          12.95±0.72     14.06±0.97      13.59±1.02     **\<0.001**
  HOMA-IR                     1.91±0.95      3.43±3.37       2.80±2.72      0.242
  MS (%)                      68.4           60              63.6           0.565

AHI -- Apnoea-hypopnoea index; hs CRP -- high sensitive C-reactive protein; HOMA-IR -- homeostasis model assessment for insulin resistance; MS -- Metabolic Syndrome.

###### 

A logistic regression model for the associations of metabolic syndrome (MS) components with neck circumference (NC) in the presence of severe OSAS.

  VARIABLES                           OR     95% CI        P VALUE
  ----------------------------------- ------ ------------- ----------
  Age (year)                          1.05   0.95--1.16    0.37
  Gender (male / female)              1.86   0.12--28.02   0.66
  Waist circumference (cm)            0.66   0.08--5.29    0.69
  Neck circumference (cm)             1.55   1.09--2.21    **0.01**
  Fasting triglyceride (≥150 mg/dl)   0.33   0.05--2.33    0.26
  Fasting blood glucose (mg/dl)       0.28   0.04--2.08    0.21
  Hypertension (≥130/85 mmHg)         1.45   0.25--8.33    0.67
  HDL cholesterol (mg/dl)             2.31   0.36--2.34    0.38
  Metabolic syndrome (%)              0.31   0.07--2.21    0.30

OSAS -- obstructive sleep apnoea syndrome; HDL -- high density lipoprotein; OR -- odds ratio; 95% CI -- 95% confidence interval; Significant value indicated in bold.

###### 

Comparisons of OSAS patients' mean results according to AHI scores.

                                     Non-severe OSAS AHI \<30 (n=19)   Severe OSAS AHI ≥30 (n=25)   P value
  ---------------------------------- --------------------------------- ---------------------------- -------------
  Age (years)                        49.89±7.47                        51.16±10.42                  0.661
  BMI                                29.83±4.53                        34.55±7.39                   **0.021**
  Waist circumference(cm)            101.67±11.96                      110.20±15.58                 0.059
  Waist/hip ratio                    0.96±0.07                         0.98±0.07                    0.06
  Neck circumference (cm)            36.11±3.18                        40.84±4.34                   **\<0.001**
  Systolic blood pressure (mm/Hg)    126.67±17.82                      134.80±23.47                 0.224
  Diastolic blood pressure (mm/Hg)   79.44±9.37                        84.80±12.62                  0.136
  Hypertension (%)                   55.6                              68                           0.405
  Diabetes Mellitus (%)              5.6                               24                           0.106
  Triglycerides (mg/dl)              142.00±56.04                      143.60±75.84                 0.940
  Total cholesterol (mg/dl)          209.17±23.69                      205.80±38.77                 0.726
  LDL cholesterol (mg/dl)            136.72±22.13                      137.04±32.70                 0.972
  HDL cholesterol (mg/dl)            45.11±11.49                       39.76±8.55                   0.087
  Hb A1c (%)                         5.69±0.51                         5.95±0.63                    0.169
  hs CRP (mg/l)                      0.50±0.49                         0.86±1.09                    0.238
  HOMA-IR                            3.82±4.32                         2.40±1.80                    0.340
  MS (%)                             61.1                              64                           0.847

AHI -- Apnoea-hypopnoea index; hs CRP -- high sensitive C-reactive protein; HOMA-IR -- homeostasis model assessment for insulin resistance; MS -- Metabolic Syndrome.

###### 

Comparisons of OSAS patient's mean results for the presence of MS.

                                    Patients with MS (n=23)   Patients without MS (n=21)   P value
  --------------------------------- ------------------------- ---------------------------- -----------
  Age (years)                       51.61±8.78                48.06±10.14                  0.230
  AHI                               35.08±19.45               32.68±20.01                  0.701
  BMI                               34.09±7.22                29.89±4.53                   **0.042**
  Waist circumference (cm)          110.43±14.05              100.44±13.48                 **0.026**
  Systolic blood pressure (mmHg)    136.79±23.10              121.88±13.28                 **0.023**
  Diastolic blood pressure (mmHg)   83.57±12.54               81.25±9.57                   0.525
  Hypertensive (%)                  81.5                      31.3                         **0.001**
  Diabetic (%)                      22.2                      6.3                          0.170
  Fasting blood glucose (mg/dl)     102.57±11.44              90.00±9.23                   **0.001**
  Triglycerides (mg/dl)             155.39±68.57              130.50±73.11                 0.264
  Total cholesterol (mg/dl)         209.82±37.86              205.69±24.74                 0.664
  LDL cholesterol (mg/dl)           138.43±31.17              135.75±23.46                 0.767
  HDL cholesterol (mg/dl)           40.89±10.16               43.56±9.90                   0.403
  HbA~1~c (%)                       5.98±0.63                 5.53±0.45                    **0.017**
  hs CRP (mg/l)                     0.76±0.91                 0.62±0.92                    0.643

AHI -- Apnoea-hypopnoea index; hs CRP -- high sensitive C-reactive protein; MS -- Metabolic Syndrome.
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